Investors
EQL Pharma develops, sells and markets medicines with a focus on niche products having no patent protection. The company currently has a smaller portfolio on the market and an extensive pipeline of unique medicines. EQL Pharma strives to maintain an open and proactive dialogue with current and potential shareholders and to give the market and society a good insight into and understanding of our business.
Stock Information
Financial Report
Financial Calendar
Financial Reports
2014
Annual Report 2014
2013
Annual Report 2013
2011
Annual Report 2011
2010
Annual Report 2010
2009
Annual Report 2009
2008
Annual Report 2008
2007
Annual Report 2007
Financial Calendar
6
May 2021
- Year-end Report April 2020 - March 2021 (Q4)
18
August 2021
- Annual General Meeting 2021, Lund